Home / Cyclophosphamide / Austria
AT ATC L01AA01 · updated 2 Nov 2026
Cyclophosphamide shortage in Austria
Is there a Cyclophosphamide shortage in Austria?
Yes. As of 2 Nov 2026, 3 Cyclophosphamide products are reported short in Austria, the first since 25 Feb 2026. The company estimate for the return is 31 Mar 2027. Main reason: manufacturing problem.
Also short in Canada, Germany, France, Italy, Spain, Belgium, Switzerland, Czechia, Sweden, Japan, Australia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Endoxan "Baxter" 1 g - Trockenstechampulle, 10 Stück limited | Baxter Healthcare GmbH | 25 Feb 2026 | 31 Mar 2027 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Endoxan "Baxter" 200 mg - Trockenstechampulle, 10 Stück limited | Baxter Healthcare GmbH | 25 Feb 2026 | 31 Mar 2027 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Endoxan "Baxter" 500 mg - Trockenstechampulle, 1 Stück limited | Baxter Healthcare GmbH | 25 Feb 2026 | 31 Mar 2027 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).